Search

Your search keyword '"Bagella, P"' showing total 14 results

Search Constraints

Start Over You searched for: Author "Bagella, P" Remove constraint Author: "Bagella, P" Topic business Remove constraint Topic: business
14 results on '"Bagella, P"'

Search Results

1. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

2. Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

3. Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014

4. Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)

5. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study

6. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

7. Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study

8. Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project

9. Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance

10. Weight Gain: A Possible Side Effect of All Antiretrovirals

11. Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

12. Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting

13. Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study

14. Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

Catalog

Books, media, physical & digital resources